Home LiteratureArticle Details
PMID: 6740333 Published · ppublish English Journal Article

An activated rasN gene: detected in late but not early passage human PA1 teratocarcinoma cells.

Science (New York, N.Y.) ·Vol. 225 ·No. 4662 ·1984-08-10 ·Pages 643-5

Tainsky MA, Cooper CS, Giovanella BC, Vande Woude GF

Abstract

Early passages of the human teratocarcinoma cell line PA1 are not tumorigenic in nude mice, while late passages are. A transforming gene present in late passages of PA1 cells was isolated as a biologically active molecular clone and is a new isolate of the human rasN locus. Its transforming activity is due to a single G---A (G, guanine; A, adenine) point mutation at the codon for amino acid 12 which changes the codon for glycine so that an aspartic acid residue is expressed. In contrast to late passage PA1 cells (passages 106, 330, and 338), DNA from the PA1 cell line at early passages (passage 36) does not yield rasN foci in DNA transfection assays. Thus, the presence of an activated rasN in PA1 cells correlates with enhanced tumorigenicity of the cell line and, more importantly, may have arisen during cell culture in vitro.

MeSH Terms
Animals Base Sequence Cell Line Cell Transformation, Neoplastic/metabolism DNA, Neoplasm/genetics Humans Mice Mice, Nude Oncogenes Teratoma/genetics Time Factors
Chemicals
DNA, Neoplasm
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Tainsky M A
Cooper C S
Giovanella B C
Vande Woude G F
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1984-08-10
Pages
643-5
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]